Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 231

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

The relationship between glucocerebrosidase mutations and Parkinson disease

Open access
Migdalska‐Richards, Anna, Schapira, Anthony H. V.·2016·Journal of Neurochemistry

Abstract

Parkinson disease ( PD ) is the second most common neurodegenerative disorder after Alzheimer disease, whereas Gaucher disease ( GD ) is the most frequent lysosomal storage disorder caused by homozygous mutations in the glucocerebrosidase ( GBA 1 ) gene. Increased risk of developing PD has been observed in both GD patients and carriers. It has been estimated that GBA 1 mutations confer a 20‐ to 30‐fold increased risk for the development of PD , and that at least 7–10% of PD patients have a GBA 1 mutation. To date, mutations in the GBA 1 gene constitute numerically the most important risk factor for PD . The type of PD associated with GBA 1 mutations ( PD ‐ GBA 1 ) is almost identical to idiopathic PD , except for a slightly younger age of onset and a tendency to more cognitive impairment. Importantly, the pathology of PD ‐ GBA 1 is identical to idiopathic PD , with nigral dopamine cell loss, Lewy bodies, and neurites containing alpha‐synuclein. The mechanism by which GBA 1 mutations increase the risk for PD is still unknown. However, given that clinical manifestation and pathological findings in PD ‐ GBA 1 patients are almost identical to those in idiopathic PD individuals, it is likely that, as in idiopathic PD , alpha‐synuclein accumulation, mitochondrial dysfunction, autophagic impairment, oxidative and endoplasmic reticulum stress may contribute to the development and progression of PD ‐ GBA 1 . Here, we review the GBA 1 gene, its role in GD , and its link with PD . image The impact of glucocerebrosidase 1 ( GBA1 ) mutations on functioning of endoplasmic reticulum (ER), lysosomes, and mitochondria. GBA1 mutations resulting in production of misfolded glucocerebrosidase (GCase) significantly affect the ER functioning. Misfolded GCase trapped in the ER leads to both an increase in the ubiquitin–proteasome system (UPS) and the ER stress. The presence of ER stress triggers the unfolded protein response (UPR) and/or endoplasmic reticulum‐associated degradation (ERAD). The prolonged activation of UPR and ERAD subsequently leads to increased apoptosis. The presence of misfolded GCase in the lysosomes together with a reduction in wild‐type GCase levels lead to a retardation of alpha‐synuclein degradation via chaperone‐mediated autophagy (CMA), which subsequently results in alpha‐synuclein accumulation and aggregation. Impaired lysosomal functioning also causes a decrease in the clearance of autophagosomes, and so their accumulation. GBA1 mutations perturb normal mitochondria functioning by increasing generation of free radical species (ROS) and decreasing adenosine triphosphate (ATP) production, oxygen consumption, and membrane potential. GBA1 mutations also lead to accumulation of dysfunctional and fragmented mitochondria. This article is part of a special issue on Parkinson disease .

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/jnc.13385

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 231

Metadata

Authors
Migdalska‐Richards, A., & Schapira, A. H. V.
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
2016-02-10
Volume
139
Issue
S1
Pages
77-90
ISSN
  • 0022-3042 (ISSN-L)
  • 1471-4159
OpenAlex
W2337871602
Cited by
231
References
4
FWCI
19.85
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The relationship between glucocerebrosidase mutations and Parkinson disease. https://app.cochat.ai/papers/10.1111/jnc.13385
The paper
Migdalska‐Richards, A., & Schapira, A. H. V. (2016). The relationship between glucocerebrosidase mutations and Parkinson disease. Journal of Neurochemistry. https://doi.org/10.1111/jnc.13385

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.